University of Wollongong

Research Online
Faculty of Science, Medicine and Health Papers: Part B

Faculty of Science, Medicine and Health

1-1-2019

Phytochemical and pharmacological studies on four Indonesian epiphytic
medicinal plants: Drynaria rigidula, Hydnophytum formicarum, Usnea
misaminensis, and Calymperes schmidtii
Ari Satia Nugraha
University of Wollongong, asn559@uowmail.edu.au

Tashi Wangchuk
University of Wollongong

Anthony C. Willis
Australian National University

Rachada Haritakun
National Science and Technology Development Agency, Thailand

Heri Sujadmiko
Gadjah Mada University

See next page for additional authors

Follow this and additional works at: https://ro.uow.edu.au/smhpapers1

Publication Details Citation
Nugraha, A., Wangchuk, T., Willis, A. C., Haritakun, R., Sujadmiko, H., & Keller, P. A. (2019). Phytochemical
and pharmacological studies on four Indonesian epiphytic medicinal plants: Drynaria rigidula,
Hydnophytum formicarum, Usnea misaminensis, and Calymperes schmidtii. Faculty of Science, Medicine
and Health - Papers: Part B. Retrieved from https://ro.uow.edu.au/smhpapers1/773

Research Online is the open access institutional repository for the University of Wollongong. For further information
contact the UOW Library: research-pubs@uow.edu.au

Phytochemical and pharmacological studies on four Indonesian epiphytic
medicinal plants: Drynaria rigidula, Hydnophytum formicarum, Usnea
misaminensis, and Calymperes schmidtii
Abstract
Phytochemical studies performed on 4 Indonesian epiphytic medicinal plants, Drynaria rigidula L.,
Hydnophytum formicarum Jack, Usnea misaminensis (Vain) Motyka, and Calymperes schmidtii Broth.,
revealed 11 known secondary metabolites (1-11), reported from these species for the first time. The
methanol extracts and their fractions were screened against infective agents and cancer cells. The
dichloromethane fractions of H. formicarum, U. misaminensis, and C. schmidtii showed activity against
lung cancer cells with IC50 values of 35, 11, and 20 µg/mL, respectively.

Publication Details
Nugraha, A. S., Wangchuk, T., Willis, A. C., Haritakun, R., Sujadmiko, H. & Keller, P. A. (2019). Phytochemical
and pharmacological studies on four Indonesian epiphytic medicinal plants: Drynaria rigidula,
Hydnophytum formicarum, Usnea misaminensis, and Calymperes schmidtii. Natural Product
Communications: an international journal for communications and reviews, 14 (6), 1-6.

Authors
Ari Satia Nugraha, Tashi Wangchuk, Anthony C. Willis, Rachada Haritakun, Heri Sujadmiko, and Paul A.
Keller

This journal article is available at Research Online: https://ro.uow.edu.au/smhpapers1/773

Original Article

Phytochemical and Pharmacological
Studies on Four Indonesian Epiphytic
Medicinal Plants: Drynaria rigidula,
Hydnophytum formicarum, Usnea
misaminensis, and Calymperes schmidtii

Natural Product Communications
June 2019–6
© The Author(s) 2019
Article reuse guidelines:
sagepub.com/journals-permissions
DOI: 10.1177/1934578X19856792
journals.sagepub.com/home/npx

Ari S. Nugraha1,2, Tashi Wangchuk1, Anthony C. Willis3, Rachada Haritakun4,
Heri Sujadmiko5, and Paul A. Keller1

Abstract
Phytochemical studies performed on 4 Indonesian epiphytic medicinal plants, Drynaria rigidula L., Hydnophytum formicarum
Jack, Usnea misaminensis (Vain) Motyka, and Calymperes schmidtii Broth., revealed 11 known secondary metabolites (1-11),
reported from these species for the first time. The methanol extracts and their fractions were screened against infective
agents and cancer cells. The dichloromethane fractions of H. formicarum, U. misaminensis, and C. schmidtii showed activity
against lung cancer cells with IC50 values of 35, 11, and 20 µg/mL, respectively.
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The archipelago of Indonesia is rich in medicinal plants
including the neglected subset of epiphytic medicinal plants.1
Our previous studies revealed the chemical constituents, and
their corresponding activities, from the rhizome of the
Indonesian epiphytic fern Drynaria rigidula L.2 Here we
report on the continued phytochemical investigations into
Indonesian epiphytic species including the leaves of D.
rigidula, and further, the whole plant of Hydnophytum formicarum Jack, an epiphytic lichen Usnea misaminensis (Vain)
motyka and an epiphytic bryophyte Calymperes schmidtii
Broth (Figure 1). The indigenous people of Indonesia have
claimed the medicinal benefits of these species including D.
rigidula to treat eye infection, a decocted pith of H. formicarum drunken to alleviate swellings and headache, whereas
U. misaminensis was traditionally used to treat fever, dysentery, inflammation, and hypertension. Usnea was claimed to
have astringent, diuretic, antiflatulent, and anti-inflammatory
activities and the decocted plant was prescribed to treat diarrhea and dysentery, aphthous ulcers, and abdominal distention.3 Calymperes schmidtii is part of the nonvascular plant
group, bryophytes, which consists of approximately 21 000
species, of which only 2% have been phytochemically studied.4,5 Compared to common medicinal plants, medicinal

uses of bryophytes are less common with reported traditional
uses of mosses including the external use of a poultice of
Calymperes sp. as insecticidal agent.6 These epiphytes reside
in moist, dense clusters, which are likely to harvest microbes,
and, therefore, these species may produce antimicrobial secondary metabolites. The limited reports of phytochemical
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Figure 1. Indonesian epiphytic medicinal plants. (a Drynaria
rigidula L, b Hynophytum formicarum jack, c Usnea misaminensis
(Vain) Motyka and d Calymperes schmidtii broth.)

data analyzing these medicinal epiphytic plant, therefore,
lead to this current investigation focusing on the chemical
and bioactivity investigations of the extracts and fractions of
these epiphytes. Specifically, we tested a range of biological
activities; as examples, against Plasmodium falciparum
given its prevalence in the region as well as the possibility of
this microorganism being responsible for some of the symptoms treated in traditional medicine in the region, and against
Mycobacterium tuberculosis as a surrogate for antimicrobial
activity as well as being a microbe in which new treatments
are still being investigated. We also tested against herpes
simplex virus type 1, cancer cell lines, and cytoxicity
testing.
The phytochemical studies on these 4 Indonesian epiphytic
medicinal plants resulted in the isolation of 11 secondary
metabolites (Figure 2). The hexane fraction from the crude
extract of the leaves of D. rigidula produced 3 major secondary
metabolites, namely campesterol 1, stigmasterol 2, and

Figure 2. Secondary metabolites isolated from 4 Indonesian
epiphytic medicinal plants, Drynaria rigidula (1-3, 4, 5), Hynophytum
formicarum (3, 6, 7), Usnea misaminensis (8, 9), Calymperes schmidtii
(10, 11).
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Figure 3. Oak ridge thermal-ellipsoid plot program drawing of
usnic acid 8 and salazinic acid 9.

β-sitosterol 3. The molecular structures were deduced by comparison of their electron impact mass spectra against the NIST
standard reference database. The corresponding dichloromethane fraction was subjected to silica column chromatography
followed by semipreparative high-performance liquid chromatography (HPLC), and resulted in the isolation of compound
4.2 A separate semipreparative HPLC protocol was applied to
the ethyl acetate fraction and the residue and gave 2 isolates,
which were characterized as kaempferol-3,7-di-O-α-l-rhamnopyranoside 42 and kaempferol-7-O-α-l-rhamnopyranosyl-4′-O-glucopyranoside 5 (spectral data supplied in
Supplemental material).7 Compound 4 was also found in a
5-fold lower yield in our previous investigation of the rhizome
D. rigidula (1.63 mg/g sample).2
Phytochemical investigations into the hexane fraction
from the initial methanol extract of H. formicarum produced 2 sterols stigmast-4-en-3-one 68 and β-sitosterol 3,9
and the aniline derivative 4-aminophenyl acetate 7 (spectral data supplied in Supplemental material). This is the
first report of these 3 compounds being isolated from this
species. Further analyses on the dichloromethane fraction
were constrained due to limited yield. Analysis of the
HPLC chromatogram of the brown shiny ethyl acetate
fraction indicated no discernable peaks, even after back
extraction with both acid and base.
The n-hexane fraction from the initial methanol extract of
U. misaminensis produced pale yellow crystals, which were
identified as usnic acid 8,10 with a second crop obtained following back extraction with dichloromethane. Extraction with
ethyl acetate followed by semipreparative HPLC resulted in
the isolation and identification of salazinic acid 911 as a white
needle crystals. The structures of 8 and 9 were confirmed by
X-ray crystallographic analysis (Figure 3) (spectral data supplied in Supplemental material).
Usnic acid and salazinic acid have been reported to possess antibacterial activities12,13 with the latter having inhibitory activity against the inflammation regulator, microsomal
prostaglandin E2 synthase-1.14 These outcomes support the
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traditional claims of the Indonesian indigenous population
with the use of U. misaminensis in infective-related dysentery and inflammation therapy.
Undertaking phytochemical studies on the moss C. schmidtii was challenging due to the limited availability of biomass.
Therefore, its isolation protocol was simplified with the defatted crude extract directly subjected to semipreparative HPLC.
A gradient eluent from 100% to 0% of solvent A (solvent A,
0.1% trifluoroacetic acid [TFA] in water; solvent B, 0.1% TFA
in acetonitrile) within 80 minutes led to the isolation of 2 benzoic acid derivatives at retention times of 39 and 43 minutes.
These major constituents (Figure 2) were assigned as methyl
2,4-dihydroxy-3,6-dimethylbenzoate 10,15 and methyl
2,4-dihydroxy-6-methylbenzoate 11,16 and this is the first
report of these compounds being isolated from an epiphytic
moss species (spectral data supplied in Supplemental material).
It is the reported active component of the commercial herbal
medicine Tadenan, which is used in therapy for benign prostate
hyperplasia and in combination therapy for prostate cancer.
Further studies revealed that the acid 10 inhibited prostate

cancer cell growth, acting as an antagonist of the human androgen receptor.17
The crude extracts from all 4 species, and their fractions,
were screened against a small range of cancer cell lines, and
for their antimicrobial activity (Table 1). The DCM fraction
of D. rigidula was cytotoxic against breast cancer cell
MCF-7 possibly due to the presence of kaemferitrin 4, which
was previously reported to have activity against the cell line
with an half-maximal inhibitory concentration (IC50) value
of 0.062 mM.18 The hexane and DCM fractions of H. formicarum inhibited lung cancer NCI-H187 cell growth and are
likely due to the component, β-sitosterol 3 being present, as
it was previously reported to possess the same action with an
IC50 value of 26.45 µg/mL.19 The DCM fraction of U. misaminensis showed broad cytotoxicity against KB cell, lung
cancer cell NCI-H187 and breast cancer cell MCF-7 with
IC50 values of 28, 11, and 30 µg/mL, respectively. The isolated constituent from this fraction, usnic acid 8, was previously reported to induce apoptosis via a reactive oxygen
scavenger-dependent mitochondrial pathway in MCF-7

Table 1. Bioactivity Testing Results of Crude Extracts and Their Fractions.
Inhibition (IC50, μg/mL)

Species
Drynaria rigidula

Hynophytum
formicarum

Usnea misaminensis

Calymperes schmidtii

Extract

KB cells

Lung cancer
NCIH187

Methanol
n-Hexane
Dichloromethane
Ethyl acetate
Residue
Methanol

-

-

18
27

n-Hexane
Dichloromethane
Ethyl acetate
Residue
Methanol
n-Hexane
Dichloromethane
Ethyl acetate
Residue
Methanol
Hexane
Dichloromethane
Ethyl acetate
Residue

28
-

18
35
31
48
11
49
38
20
49
-

30
-

Breast cancer MCF-7 Vero cells

HSV-1

TB

Pf

na
na
na
na
na
-

na
na
na
na
na
-

na
na
na
na
na
-

na
na
na
na
na
-

49
49
20
--

48
-

50
-

-

-, inactive; na, not available; HSV, Herpes simplex virus; TB, tuberculosis; Pf, Plasmodium falciparum. IC50, half-maximal inhibitory concentration;
IC50 positive control: Ellipticine = 1.47 μg/mL against KB cell, 2.47 μg/mL against lung cancer NCI-H187, 1.83 μg/mL against vero cell; Tamoxifen =
6.13 μg/mL against breast cancer MCF-7; Mafloquine = 0.029 μg/mL against Plasmodium falciparum; Streptomycin = 0.156 μg/mL against Mycobacterium
tuberculosis; Acyclovir = 7.86 μg/mL against HSV-1.

4
cells20 . Interestingly, the DCM fraction also showed that
anti-mycobacterium activity with usnic acid 8 was previously reported with an MIC value of 62.5 µg/mL against
Mycobacterium tuberculosis H37Rv.21 The crude extract and
fractions from C. schmidtii inhibited lung cancer cell growth
and HSV-1; however, compounds 10 and 11 have previously
been reported for anticancer and anti-viral activities.

Conclusion
Studies on 4 Indonesian epiphytic medicinal plants, D. rigidula, H. formicarum, U. misaminensis, and C. schmidtii, successfully revealed 11 major constituents. Lung cancer cells
NCI-H187 showed sensitivity against most of the crude
methanol extracts and their subfractions with the exception
of D. rigidula. The dichloromethane subfraction of U. misaminensis exerts cytotoxicity against KB-oral cancer cell,
lung cancer cell NCI-H187, and breast cancer cell MCF-7.

Experimental
Plant Material
Epiphytic medicinal plant samples, D. rigudula, U. misaminensis, and C. schmidtii, were collected from Malabar forest
surrounding Bondowoso, Indonesia during wet season on
February 2010 and sample vouchers are deposited under
accession codes DRL, UM, and BSp, respectively.
Hynophytum formicarum was purchased from the Traditional
Market at Klaten, Jawa Tengah-Indonesia in which the sample originated from West Papua-Indonesia. The voucher
sample of H. formicarum was deposited under accession
number HF. The Drynaria, Hydnophytum, and Usnea were
identified at Faculty of Pharmacy, University of Jember
Indonesia. The C. schmidtii was identified by Mr Heri
Sujadmiko, a bryologist at Faculty of Biology, Gadjah Mada
University, Indonesia. Samples were cleaned, washed, and
cut drying under sun shade. The dried samples were then
separately pulverized using a grinding machine.

Extraction and Constituent Isolation of Leaves of
Drynaria rigidula
To leaf powder (500 g) was added MeOH (5.0 L) and the
mixture stirred for 48 hours. The suspension was filtered and
the supernatant vaccuum dried to produce crude leaves
extract (48.1 g). Liquid-liquid fractionation from the leaves
extract produced n-hexane (11.7307 g), DCM (2.3467 g),
EtOAc (10.8527 g), and residual (22.9089 g) fractions.
The hexane fraction was prepared for gas chromatography mass spectrometry (GC-MS) analysis with samples (5
mg/mL) prepared by treating the solution with BSTFA (N,Obis(trimetylsilyl)trifluoroacetamide) for 12 hours. The
trimethylsilyl derivatives were then subjected to GC-MS and
the resulting spectra compared with spectra in the NIST08
database. This revealed 3 major secondary metabolites,
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namely campesterol 1, stigmasterol 2, and β-sitosterol 3. The
DCM fraction (1.8755 g) was subjected to a silica gel column chromatography plug (2 × 30 cm) and gradient elution
with n-hexane, transitioning to EtOAc and EtOAc to ACN to
produce 122 fractions. Analysis by thin-layer chromatography (TLC) allowed sample pooling to produce 13 fractions.
The subfraction 10 (150 mg) was loaded into a short
RP-column (1.5 × 3.0 cm) and washed with MeOH (50 mL)
and EtOAc (100 mL). The relevant fraction(s) were then
concentrated to 10 mL and subjected to semipreparative
HPLC with a gradient elution from 100% to 50% of solvent
A within 40 minutes (solvent A: 0.1% TFA in H2O; solvent
B: 0.1% TFA in ACN) to yield kaempferol-7-O-α-l-rhamnopyranosyl-4′-O-glucopyranoside 5 (20 mg). The EtOAc fraction (350 mg) was subjected to short silica gel column
chromatography (2 cm × 5 cm) and elution with
ACN:MeOH:H2O (8:1:1) produced a 200 mL fraction, which
was concentrated to 7 mL. The sample was then injected in 7
blocks in preparative HPLC with a gradient elution from
100% to 80% solvent A (0.1% TFA in H2O) in 40 minutes
with solvent B (0.1% TFA in acetonitrile) to produce kaempferitrin 4 (100 mg) and kaempferol-7-O-α-l-rhamnopyranosyl-4′-O-glucopyranoside 5 (28 mg).

Extraction and Constituent Isolation of Hydnophytum
formicarum
A suspension of the whole plant powder (600 g) in MeOH (5.0
L) was stirred for 24 hours, filtered, and the supernatant vaccuum dried to produce dried extract (36.2 g). A portion of dried
extract (10 g) was fractionated with n-hexane (601.0 mg),
DCM (150.5 mg), EtOAc (3453.8 mg), and residue (3029.7
mg). The n-hexane fraction (601.0 mg) was subjected to flash
silica column chromatography (2-cm diameter, 30-cm length)
and elution starting with n-hexane, transitioning to n-hexane
(0.2 L), n-hexane:EtOAc (9.5:0.5, 0.5 L), n-hexane:EtOAc
(9:1, 0.1 L), n-hexane:EtOAc (8.5:1.5, 0.4 L), n-hexane:EtOAc
(8:2, 0.3 L), n-hexane:EtOAc (7.5:2.5, 0.2 L), n-hexane:EtOAc
(5:5, 0.1 L), n-hexane:EtOAc (2.5:7.5, 0.1 L), EtOAc (100 L),
EtOAc:ACN (5:5, 0.1 L), ACN (0.1 L), ACN:MeOH:H2O
(9:0.5:0.5, 0.1 L), and ACN:MeOH:H2O (8:1:1, 0.1 L) to produce 110 fractions. TLC analysis of the fractions allowed isolation of crystals of compound 6 (4.1 mg) from fractions 16 and
17, and crystals of compound 3 (51.0 mg) from fractions 22 to
27. Fractions 39 to 42 were pooled and subjected to silica gel
column chromatography (0.5-cm diameter, 6-cm length) and
elution with EtOAc produced compound 7 (3.1 mg).

Extraction and Constituent Isolation of Usnea
misaminensis
Dried powder (200 g) was stirred with MeOH for 48 hours at
room temperature and then filtered and the supernatant vaccuum dried to produce crude extract (16.6 g). Liquid-liquid
fractionation of the rhizome extract produced n-hexane (1.28
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g), DCM (3.26 g), and EtOAc (4.81 g), fractions along with
a residue (1.45 g). The n-hexane fraction (0.2 g) was subjected to a short C18 column (2 × 4 cm) and eluted with
EtOAc. To this EtOAc fraction was added dropwise water
and the resulting precipitate was collected, vacuum dried,
and redissolved in DCM (2 mL) and left allowing the formation of yellow crystals of usnic acid 8 (60.5 mg). The DCM
fraction (1 g) was subjected to short silica gel column chromatography (2 × 15 cm) and elution with n-hexane gave salazinic acid 9 (650 mg). The EtOAc fraction (0.5 g) was
prepared for HPLC analysis by filteration through a short C18
column (5 mL) and elution with DCM (100 mL) and
MeOH:ACN (1:1, 100 mL) and concentrated to 25 mL.
Preparative HPLC was employed with a gradient elution
from 80% into 50% solvent A (0.1% TFA in H2O) within 50
minutes with solvent B (0.1% TFA in ACN). The fraction
collected at tR 25 minutes was allowed to stand and needle
crystals formed, identified as salazinic acid 9 (44.1 mg) by
X-ray crystallographic analysis.

Crystallographic Data of Compound 8 (Usnic Acid)
Crystal data. Compound 8. C18H12O10•H2O, M = 406.30, T
= 150K, monoclinic, space group P21/c, Z = 4, a =
21.5208(11), b = 4.09693(14), c = 19.0128(7)Å, β =
103.744(5)°, V = 1628.33(12) Å3, Dx = 1.657 g/cm3, Cu Kα
radiation, λ = 1.54180 Å, 15 785 reflections measured (2θ
= 4–140°) merged to 3 046 unique data, R = 0.043 [for
2547 data with I > 2σ(I)], Rw = 0.104 [all data], S = 1.02.
Structure determination of compound 8. Images were measured on an Agilent SuperNova diffractometer (Cu Kα
radiation, mirror monochromator, λ = 1.54180 Å) and data
extracted using the CrysAlis PRO package.22 Structure
solution was by direct methods (SIR92).23 The structure
was refined using the CRYSTALS program package.24
Atomic coordinates, bond lengths and angles, and displacement parameters have been deposited at the
Cambridge Crystallographic Data Centre (CCDC no.
1567131). These data can be obtained free-of-charge via
www.ccdc.cam.ac.uk/data_requerst/cif, by emailing data_
request@ccdc.cam.ac.uk, or by contacting The Cambridge
Crystallographic Data Centre, 12 Union Road, Cambridge
CB2 1EZ, UK; fax: +44 1223 336033.

Kα radiation, graphite monochromator, λ = 0.71073 Å) and
data extracted using the DENZO package.25 Structure solution was by direct methods (SIR92).23 The structure was
refined using the CRYSTALS program package.24 Atomic
coordinates, bond lengths and angles, and displacement
parameters have been deposited at the Cambridge
Crystallographic Data Centre (CCDC no. 1567130).

Extraction and Constituent Isolation of Calymperes
schmidtii
A suspension of powdered of C. schmidtii whole plant (20 g)
in MeOH (1 L) was stirred for 24 hours, filtered, and the filtrate concentrated to produce a dark green sticky semisolid
(1.1 g). The crude extract in MeOH (100 mL) was liquid-liquid partitioned with n-hexane and both fractions were separately concentrated to produce an n-hexane fraction (360
mg) and a MeOH fraction (769 mg). A portion of the methanol fraction (250 mg) was applied into a short C18 silica column (1.5 × 5 cm) and was then eluted with MeOH (50 mL)
to give a solution, which was concentrated to 20 mL and filtered through a HPLC sample filter (0.45 µm). Analysis by
HPLC using a gradient elution from 100% of solvent A
(0.1% TFA in H2O) to 0% of solvent A within 80 minutes
(solvent B, 0.1% TFA in ACN) separated compounds 10 and
11 at retention times 39 and 45 minutes, respectively. Both
fractions were vacuum dried to give pale yellow solids,
methyl 2,4-dihydroxy-3,6-dimethyl-benzoate 10, and methyl
2,4-dihydroxy-6-methylbenzoate 11.

Bioactivity Testing
Antimalarial activity was determined against Plasmodium
falciparum K1 based on the microculture radioisotope
technique.26 Cytotoxicity was tested against KB-oral cancer cell, lung cancer cell NCI-H187, breast cancer cell
MCF7, and vero cells based on the resazurin microplate
assay. The anti-TB assay utilized the Mycobacterium
tuberculosis H37Ra strain using a green fluorescent protein microplate assay. Antiviral activity was tested against
herpes simplex virus type 1 using a green fluorescent protein assay.27
Acknowledgments

Crystallographic Data of Compound 9 (Salazinic
Acid)
Crystal data. Compound 9. C18H16O7, M = 344.32, T = 200
K, orthorhombic, space group P212121, Z = 8, a = 8.0273(1),
b = 18.9068(3), c = 20.2525(3)Å, V = 3073.73(8)Å3, Dx =
1.488 g/cm3, Mo Kα radiation, λ = 0.71073 Å, 43 467 reflections measured (2θ = 6–60°) merged to 5 024 unique data, R
= 0.034 (for 4 436 data with I > 2σ(I)), Rw = 0.087 (all data),
S = 0.99. Structure determination of compound 9. Images
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